ContactContact

Corporate Governance

The members of the Board of Directors and the Executive Committee of Galenica AG are qualified and experienced persons. Most of them have known and accompanied Galenica for many years and are committed to the successful further development of the company with their professional competence.

Board of Directors

Daniela Bosshardt

Daniela Bosshardt
Chairwoman of the Board of Directors

  • Elected since 2017
  • Born 1972, Swiss citizen
  • Pharmacist, Federal Diploma in Pharmacy, Federal Institute of Technology, Zurich (ETHZ)
  • Financial analyst at Bank am Bellevue (1998–2002) and M2 Capital (2003–2004)
  • Management consultant in the pharmaceutical, medical technology and biotechnology sectors since 2004
  • Member of the Board of Directors of Reprisk Ltd.
  • Former Board mandates at Vifor Pharma Ltd. (2008–2019), investiere.ch - Verve Capital Partners Ltd. (2017–2019) and Nobel Biocare Ltd. (2010–2014)
Prof. Dr. Michel Burnier

Prof. Dr. Michel Burnier

  • Elected since 2017
  • Born 1953, Swiss citizen
  • Swiss-registered Doctor of Internal Medicine and Nephrology
  • Honorary professor, University of Lausanne
  • Member of the Swiss Society of Nephrology (former President), European Society of Hypertension (former council member and Treasurer) and Swiss Society of Hypertension (former President)
  • Formerly a member of the Medicines Committee of the Swiss Association of Pharmacists (until 2001) and the Board of Swissmedic (2002–2010)
  • Member of the Board of Directors of Speedel Holding Ltd. from 2007 to 2009
  • Member of the Board of Directors of Vifor Pharma Ltd.
Fritz Hirsbrunner

Fritz Hirsbrunner

  • Elected since 2017
  • Born 1949, Swiss citizen
  • Lic. oec., HEC University of Lausanne / Senior Executive Program, IMD, Lausanne
  • 1972–1977 Controller at Ciba-Geigy
  • Joined the former Galenica Group in 1977 as Assistant to the Corporate Executive Committee; member of the Corporate Executive Committee, Deputy CEO and CFO from 1992 to 2011. Head Investor Relations from 2012 to 2014 (mandate basis)
  • Member of the Board of Trustees of IST Investmentstiftung
  • Member of the Board of Directors of Berlac Ltd., IVF Hartmann Holding Ltd. and Vencap 6 Ltd.
  • Former Board member of Vifor Pharma Ltd. (2012–2019)
Dr. Philippe Nussbaumer

Dr. Philippe Nussbaumer

  • Elected since 2017
  • Born 1969, Swiss citizen
  • FPH Pharmacist, Federal Diploma / PhD in Pharmaceutical Sciences, University of Geneva / dipl. oec. HEC, University of Lausanne
  • Federal Ski Instructor Diploma and Federal Expert J+S; since 2004, Vice-President of the Swiss Snowsports School of Neuchâtel / Les Bugnenets
  • Owner and president of the Pharmacie Centrale and the Pharmacie de la Gare in La Chaux-de-Fonds
  • Since 2007, founder and administrator of the Ecopharma pharmacy brand
  • Since 2014, founder and member of the Board of Directors of the Medi-Centre Ltd. medical centre in La Chaux-de-Fonds
  • Member of the Board of Directors of Veripharm Ltd.
Dr. Andreas Walde

Dr. Andreas Walde

  • Elected since 2017
  • Born 1962, Swiss citizen
  • Attorney-at-law and doctorate in law, University of Basel
  • Various legal and management positions in the chemical and pharmaceutical industry for more than 30 years with specialisation in financial and corporate structures, M&A, risk management, compliance and corporate governance: 1988–1996 at Roche, 1998–2010 at Clariant and 2012–2013 at Petroplus, in the latter two among others as Group General Counsel; General Secretary of Vifor Pharma Ltd., former Galenica Group, since 2013
  • Member of the Board of Swiss-Holdings, and the Board of Scienceindustries
  • Former (Board) mandates for several private and (non-Swiss) listed companies as well as former member of the Board of the Society of Swiss Enterprises in Germany

Corporate Executive Committee

Marc Werner

Marc Werner
CEO Galenica Group

  • Born in 1967, Swiss citizen
  • Federal certified marketing director
  • Various management training courses at the International Institute for Management Development (IMD) in Lausanne, London Business School and Harvard Business School
  • 1990 to 1995 Head of Sales at Sinomec Ltd (Zellweger Uster Ltd)
  • 1995 to 1996 Head of Product Management Photofinishing, Federation of Migros Co-operatives
  • 1997 to 2000 Head of Marketing and Sales at Minolta (Switzerland) Ltd
  • 2000 to 2004 Head of Marketing & Sales at Bluewin Ltd
  • Joined the Swisscom Group in 2005 as head of Marketing & Sales at Swisscom Ltd, head of Service from 2012 to 2013, member of the Group Executive Board from 2013, head of Private Customers until 2015 and head of Sales & Services from 2016 to 2019
  • Since 2020, CEO and member of the Corporate Executive Committee of the Galenica Group
Felix Burkhard

Felix Burkhard
CFO Galenica Group

  • Born 1966, Swiss citizen
  • Lic. oec., HSG University of St. Gallen (HSG), and Swiss certified accountant
  • 1991–1995 Financial Auditor at Revisuisse PriceWaterhouse (Bern) and Head of Finance and Controlling at Amidro Ltd. (Biel-Bienne)
  • Joined the former Galenica Group in 1996 as Corporate Controller; Deputy Head Retail Business sector from 2000; in addition, Head of the Amavita pharmacy chain from 2008; Head Retail Business sector from 2010 to 2015; member of the Corporate Executive Committee of the Galenica Group since 2010; Head Strategic Projects from 2015 to 2017
  • CFO Galenica Group since 2017
Daniele Madonna

Daniele Madonna
Head Retail Business sector

  • Born 1977, Swiss citizen
  • Federal Diploma in Pharmacy from the Federal Institute of Technology, Zurich (ETHZ)
  • Professional training FPH in Retail Pharmacy
  • CAS in General Management at the University of St. Gallen (HSG) and Program for Executive Development (PED) at IMD, Lausanne
  • 2003–2004 Pharmacist at the Olympia Pharmacy and the Victoria Pharmacy in Zurich
  • Joined the former Galenica Group in 2004 as Manager of the Coop Vitality pharmacy in Tenero; Regional Sales Manager at Coop Vitality from 2010 to 2014; CEO of Coop Vitality Ltd. in Bern from 2014 to 2017
  • Since 2017 Head Retail Business sector and member of the Corporate Executive Committee of the Galenica Group
Dr. Thomas F. Szuran

Dr. Thomas F. Szuran
Head Products & Brands Business sector

  • Born 1967, Swiss citizen
  • Dr. sc. nat. Federal Institute of Technology (ETH) Zurich
  • Various roles at Abbott Laboratories between 1997 and 2002, including Sales & Marketing Manager for the Eastern European & Mediterranean region
  • Sales Director at Pfizer Switzerland (Zurich) from 2002 to 2005 and Country Manager at Pfizer in Israel from 2005 to 2007
  • Joined Biomed Ltd. (Dübendorf) in 2008 as Marketing Director, and was CEO of Biomed Ltd. from 2011 to 2018
  • Since 2012 member of the Executive Board and since 2013 President of the Association of the Swiss Self-Medication Industry (ASSGP)
  • Head Products & Brands Business sector and member of the Corporate Executive Committee of the Galenica Group since 2019
Christoph Amstutz

Christoph Amstutz
Head Services Business sector

  • Born 1963, Swiss citizen
  • Partial studies in pharmacy, Federal Institute of Technology, Zurich (ETHZ)
  • Degree in Marketing Management, University of Bern, GfM/IBM
  • 1988–2004 medical representative and product manager at UCB-Pharma AG (Zurich); Head of Marketing at UCB-Pharma GmbH (Kerpen, Germany); General Manager at UCB-Pharma Ltd. (Zurich); 2004–2007 Business Unit Manager CNS / Pain and member of the Executive Board at Bristol-Myers Squibb GmbH (Baar); 2007–2010 CEO of Globopharm Ltd. (Egg/Zurich)
  • Head of G-Pharma Ltd. from 2010 to 2011; Head of Alloga Ltd. in 2011; Head Services Business Sector since 2015
  • Member of the Corporate Executive Committee of Galenica Group since 2017

Contact

Galenica Ltd.

Investors
Untermattweg 8
3027 Bern

Tel. +41 58 852 85 29
Fax +41 58 852 85 35